Prognostic significance of human papillomavirus (HPV) status and expression of selected markers (HER2/neu, EGFR, VEGF, CD34, p63, p53 and Ki67/MIB-1) on outcome after (chemo-) radiotherapy in patients with squamous cell carcinoma of uterine cervix

Pathology and Oncology Research

Volumn 20, Issue 1, 2014, Pages 131-137

  Vosmik, Milan ^a   Laco, Jan ^a   Sirak, Igor ^a   Beranek, Martin ^a   Hovorkova, Eva ^a   Vosmikova, Hana ^a   Drastikova, Monika ^a   Hodek, Miroslav ^a   Zoul, Zdenek ^a   Odrazka, Karel ^a   Petera, Jiri ^a  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

Human papillomavirus; Immunohistochemistry; Prognostic factors; Squamous cell carcinoma; Uterine cervix

Indexed keywords

CD34 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; KI 67 ANTIGEN; PROTEIN P53; PROTEIN P63; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CHEMORADIOTHERAPY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PROBABILITY; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TREATMENT RESPONSE; UTERINE CERVIX CARCINOMA; VERY ELDERLY; VIRUS EXAMINATION; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD34; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION; HUMANS; KI-67 ANTIGEN; MEMBRANE PROTEINS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84896028033     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-013-9674-5     Document Type: Article

References (32)

1. Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, Williams CJ (2001) Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 358:781-786 (Pubitemid 32868726)
2. Gondi V, Bentzen SM, Sklenar KL, Dunn EF, Petereit DG, Tannehill SP, Straub M, Bradley KA (2012) Severe late toxicities following concomitant chemoradiotherapy compared to radiotherapy alone incervical cancer: an inter-era analysis. Int J Radiat Oncol Biol Phys 84:973-982. doi:10.1016/j.ijrobp.2012. 01.064
3. Petera J, Sirak I, Beranek M, Vosmik M, Drastikova M, Paulikova S, Soumarova R (2011) Molecular predictive factors of outcome of radiotherapy in cervical cancer. Neoplasma 58:469-475
4. Sirák I, Petera J, Odrážka K, Doležel M, Zoul Z, Vaculíková M (2006) Chemotherapy intensity importance in concurrent chemoradiotherapy of locally advanced cervical cancer. Ceska Gynekol 71:308-311
5. Petera J, Odrážka K, Doležel M, Zoul Z, Vaculíková M, Šefrová J, Sirák I (2007) Extended field radiotherapy and high-dose brachytherapy combined with chemotherapy in patients with locally advanced cervical carcinoma. Ceska Gynekol 72:126-130
6. Sirák I, Petera J, Zoul Z (2008) The influence of cisplatin dose upon survival in concurrent chemoradiotherapy of locally advanced cervical carcinoma with weekly cisplatin. Acta Medica (Hradec Kralove) 51:95-99
7. Siriaunkgul S, Suwiwat S, Settakorn J, Khunamornpong S, Tungsinmunkong K, Boonthum A, Chaisuksunt V, Lekawanvijit S, Srisomboon J, Thorner PS (2008) HPV genotyping in cervical cancer in Northern Thailand: adapting the linear array HPV assay for use on paraffin-embedded tissue. Gynecol Oncol 108:555-560. doi:10.1016/j.ygyno.2007.11.016
8. Harima Y, Sawada S, Nagata K, Sougawa M, Ohnishi T (2002) Human papilloma virus (HPV) DNA associated with prognosis of cervical cancer after radiotherapy. Int J Radiat Oncol Biol Phys 52:1345-1351 (Pubitemid 34296494)
9. Lindel K, Burri P, Studer HU, Altermatt HJ, Greiner RH, Gruber G (2005) Human papillomavirus status in advanced cervical cancer: predictive and prognostic significance for curative radiation treatment. Int J Gynecol Cancer 15:278-284 (Pubitemid 40396965)
10. Herrington CS (1999) Do HPV-negative cervical carcinomas exist? - revisited. J Pathol 189:1-3
11. Lee CM, Shrieve DC, Zempolich KA, Lee RJ, Hammond E, Handrahan DL, Gaffney DK (2005) Correlation between human epidermal growth factor receptor family (EGFR, HER2, HER3, HER4), phosphorylated Akt (P-Akt), and clinical outcomes after radiation therapy in carcinoma of the cervix. Gynecol Oncol 99:415-421 (Pubitemid 41502854)
12. Yamashita H, Murakami N, Asari T, Okuma K, Ohtomo K, Nakagawa K (2008) Correlation among six biologic factors (p53, p21(WAF1), MIB-1, EGFR, HER2, and Bcl-2) and clinical outcomes after curative chemoradiation therapy in squamous cell cervical cancer. Int J Radiat Oncol Biol Phys 74:1165-1172. doi:10.1016/j.ijrobp.2008.09.005
13. Niibe Y, Nakano T, Ohno T, Suzuki Y, Oka K, Tsujii H (2003) Prognostic significance of c-erbB-2/HER2 expression in advanced uterine cervical carcinoma with para-aortic lymph node metastasis treated with radiation therapy. Int J Gynecol Cancer 13:849-855 (Pubitemid 38235231)
14. Shen L, Shui Y, Wang X, Sheng L, Yang Z, Xue D, Wei Q (2008) EGFR and HER2 expression in primary cervical cancers and corresponding lymph node metastases: implications for targeted radiotherapy. BMC Cancer 8:232. doi:10.1186/1471-2407-8-232
15. Noordhuis MG, Eijsink JJ, Ten Hoor KA, Roossink F, Hollema H, Arts HJ, Pras E, Maduro JH, Reyners AK, de Bock GH, Wisman GB, Schuuring E, van der Zee AG (2009) Expression of epidermal growth factor receptor (EGFR) and activated EGFR predict poor response to (chemo)radiation and survival in cervical cancer. Clin Cancer Res 15:7389-7397. doi:10.1158/1078-0432.CCR-09-1149
16. Cho NH, Kim YB, Park TK, Kim GE, Park K, Song KJ (2003) P63 and EGFR as prognostic predictors in stage IIB radiation-treated cervical squamous cell carcinoma. Gynecol Oncol 91:346-353 (Pubitemid 37351026)
17. Loncaster JA, Cooper RA, Logue JP, Davidson SE, Hunter RD, West CM (2000) Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix. Br J Cancer 83:620-625 (Pubitemid 30636303)
18. Kang JO, Hong SE (2004) The prognostic effect of VEGF expression in squamous cell carcinoma of the cervix treated with radiation therapy alone. J Korean Med Sci 19:693-697
19. Gaffney DK, Haslam D, Tsodikov A, Hammond E, Seaman J, Holden J, Lee RJ, Zempolich K, Dodson M (2003) Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy. Int J Radiat Oncol Biol Phys 56:922-928 (Pubitemid 36794022)
20. Randall LM, Monk BJ, Darcy KM, Tian C, Burger RA, Liao SY, Peters WA, Stock RJ, Fruehauf JP (2009) Markers of angiogenesis in high-risk, early-stage cervical cancer: a Gynecologic Oncology Group study. Gynecol Oncol 112:583-589. doi:10.1016/j.ygyno.2008.11.013
21. Oka K, Suzuki Y, Nakano T (2000) Expression of p27 and p53 in cervical squamous cell carcinoma patients treated with radiotherapy alone: radiotherapeutic effect and prognosis. Cancer 88:2766-2773 (Pubitemid 30417937)
22. Jain D, Srinivasan R, Patel FD, Kumari Gupta S (2003) Evaluation of p53 and Bcl-2 expression as prognostic markers in invasive cervical carcinoma stage IIb/III patients treated by radiotherapy. Gynecol Oncol 88:22-28 (Pubitemid 36062661)
23. Lindström AK, Stendahl U, Tot T, Lidström BM, Hellberg D (2007) Predicting the outcome of squamous cell carcinoma of the uterine cervix using combinations of individual tumor marker expressions. Anticancer Res 27:1609-1615
24. Ebara T, Mitsuhashi N, Saito Y, Sakurai H, Hasegawa M, Takahashi M, Takahashi T, Hayakawa K, Niibe H (1996) Prognostic significance of immunohistochemically detected p53 protein expression in stage IIIB squamous cell carcinoma of the uterine cervix treated with radiation therapy alone. Gynecol Oncol 63:216-218 (Pubitemid 26398602)
25. Ishikawa H, Mitsuhashi N, Sakurai H, Maebayashi K, Niibe H (2001) The effects of p53 status and human papillomavirus infection on the clinical outcome of patients with stage IIIB cervical carcinoma treated with radiation therapy alone. Cancer 91:80-89 (Pubitemid 32052617)
26. Wootipoom V, Lekhyananda N, Phungrassami T, Boonyaphiphat P, Thongsuksai P (2004) Prognostic significance of Bax, Bcl-2, and p53 expressions in cervical squamous cell carcinoma treated by radiotherapy. Gynecol Oncol 94:636-642 (Pubitemid 39194454)
27. Nakano T, Oka K, Ishikawa A, Morita S (1998) Immunohistochemical prediction of radiation response and local control in radiation therapy for cervical cancer. Cancer Detect Prev 22:120-128 (Pubitemid 28159333)
28. Pillai MR, Jayaprakash PG, Nair MK (1998) Tumour-proliferative fraction and growth factor expression as markers of tumour response to radiotherapy in cancer of the uterine cervix. J Cancer Res Clin Oncol 124:456-461 (Pubitemid 28407580)
29. Suzuki M, Tsukagoshi S, Saga Y, Ohwada M, Sato I (2000) Assessment of proliferation index with MIB-1 as a prognostic factor in radiation therapy for cervical cancer. Gynecol Oncol 79:300-304
30. Oka K, Arai T (1996) MIB1 growth fraction is not related to prognosis in cervical squamous cell carcinoma treated with radiotherapy. Int J Gynecol Pathol 15:23-27 (Pubitemid 26006730)
31. Levine EL, Renehan A, Gossiel R, Davidson SE, Roberts SA, Chadwick C, Wilks DP, Potten CS, Hendry JH, Hunter RD et al (1995) Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma. Radiother Oncol 37:1-9
32. Sobin LH, Wittekind C (2002) UICC international union against cancer TNM classification of malignant tumours, 6th edn. Wiley-Liss, New York